相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
Linda M. de Vries et al.
PHARMACOECONOMICS (2019)
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S. Cooke et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs
Lindsey Hiebert et al.
VALUE IN HEALTH REGIONAL ISSUES (2019)
Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum
Alastair Heffernan et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Robert Hecht et al.
HEALTH POLICY AND PLANNING (2018)
Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China
Yun Lu et al.
PLOS ONE (2018)
Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China
Hai Chen et al.
PLOS ONE (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
Guo-Feng Chen et al.
PLOS ONE (2016)
The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought
Thomas Wilkinson et al.
VALUE IN HEALTH (2016)
County-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
Beth Woods et al.
VALUE IN HEALTH (2016)
Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services
Jianhua Li et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2013)
The Effect of Hepatitis C Treatment Response on Medical Costs: A Longitudinal Analysis in an Integrated Care Setting
M. Michele Manos et al.
JOURNAL OF MANAGED CARE PHARMACY (2013)
High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China
Yan-Heng Zhou et al.
PLOS ONE (2012)
Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling
Adrian E. Raftery et al.
BIOMETRICS (2010)
Assessment of Total Economic Burden of Chronic Hepatitis B (CHB)-Related Diseases in Beijing and Guangzhou, China
Min Hu et al.
VALUE IN HEALTH (2009)
Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)
Garry R. Barton et al.
VALUE IN HEALTH (2008)
Evolution of China's response to HIV/AIDS
Zunyou Wu et al.
LANCET (2007)
Relative pleasures: Drugs, development and modern dependencies in Asia's Golden Triangle
C Lyttleton
DEVELOPMENT AND CHANGE (2004)
分享论文
